Nath A, Psooy K, Martin C, Knudsen B, Magnuson D S, Haughey N, Geiger J D
Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
J Virol. 1996 Mar;70(3):1475-80. doi: 10.1128/JVI.70.3.1475-1480.1996.
Tat is an 86- to 104-amino-acid viral protein that activates human immunodeficiency virus type 1 expression, modifies several cellular functions, and causes neurotoxicity. Here, we determined the extent to which peptide fragments of human immunodeficiency virus type 1 BRU Tat1-86 produced neurotoxicity, increased levels of intracellular calcium ([Ca2+]i), and affected neuronal excitability. Tat31-61 but not Tat48-85 dose dependently increased cytotoxicity and levels of [Ca2+]i in cultured human fetal brain cells. Similarly, Tat31-61 but not Tat48-85 depolarized rat hippocampal CA1 neurons in slices of rat brain. The neurotoxicity and increases in [Ca2+]i could be significantly inhibited by non-N-methyl-D-aspartate excitatory amino acid receptor antagonists. Shorter 15-mer peptides which overlapped by 10 amino acids each and which represented the entire sequence of Tat1-86 failed to produce any measurable neurotoxicity. Although it remains to be determined if Tat acts directly on neurons and/or indirectly via glial cells, these findings do suggest that Tat neurotoxicity is conformationally dependent, that the active site resides within the first exon of Tat between residues 31 to 61, and that these effects are mediated at least in part by excitatory amino acid receptors.
Tat是一种由86至104个氨基酸组成的病毒蛋白,可激活1型人类免疫缺陷病毒的表达,改变多种细胞功能,并导致神经毒性。在此,我们确定了1型人类免疫缺陷病毒BRU Tat1-86的肽片段产生神经毒性、增加细胞内钙([Ca2+]i)水平以及影响神经元兴奋性的程度。Tat31-61而非Tat48-85剂量依赖性地增加了培养的人胎脑细胞的细胞毒性和[Ca2+]i水平。同样,Tat31-61而非Tat48-85使大鼠脑切片中的大鼠海马CA1神经元去极化。非N-甲基-D-天冬氨酸兴奋性氨基酸受体拮抗剂可显著抑制神经毒性和[Ca2+]i的增加。每个重叠10个氨基酸且代表Tat1-86完整序列的较短的15聚体肽未能产生任何可测量的神经毒性。尽管Tat是否直接作用于神经元和/或通过神经胶质细胞间接作用仍有待确定,但这些发现确实表明Tat神经毒性取决于构象,活性位点位于Tat第一个外显子中31至61位残基之间,并且这些作用至少部分由兴奋性氨基酸受体介导。